drugset / Trial / NCT00493896
Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
This is a pilot study to evaluate safety of fondaparinux and enoxaparin in terms of bleeding and development of thrombocytopenia in the medical ICU population.
Timeline
- Start
- 2007-07
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |
| Subject | Fondaparinux | Other / unclassified | 2.5 mg | Subcutaneous |